Biotechnology/Systems biology

Meat has got competition: Plant-based sausage alternatives made from soy, peas or lupins have conquered supermarket shelves. However, there are differences: For example, plant-based sausages lack the right crunch when you bite into them. Researchers at the Max Planck Institute for Polymer Research in Mainz have now found a way to improve the mouthfeel so that vegetarian and vegan sausages resemble the animal original even more.

Provence is famous for its lavender fields. In July and August, the blue and purple flowers are not only beautiful to look at: The scent also attracts bees and butterflies, which feast on the sweet nectar. Because of its essential oils, the plant has also been valued as a remedy for centuries and is still used today for the production of medicines and natural cosmetics. A research team now wants to establish lavender cultivation in the Swabian Jura in order to obtain raw materials for the bioeconomy from it.

Medicine has always relied on the healing powers of nature. Plant-based active ingredients are therefore a sought-after raw material for both the pharmaceutical and cosmetics industries. However, their extraction from medicinal plants such as thyme and chamomile is subject to natural fluctuations, so that the active ingredient content varies. In addition, climate change and barren soils further reduce the concentrations of the ingredients, thus lowering the quality of conventionally extracted essential oil.

The use of high-quality by-products from the local agricultural and food industry and the associated return of valuable nutrients to the food economy are integral components of Mushlabs' strategy. The startup is one of the first biotech companies in the world to use byproducts for the liquid fermentation of mycelium from edible mushrooms. Bitburger's venture arm, Bitburger Ventures, had already joined Mushlabs in 2019. Now a production-level collaboration is starting.

Some revolutions are slow in coming. Like the research work of the French company Carbios, which spent ten years pursuing its idea of developing a polyethylene (PET)-degrading enzyme. In 2013, just two years after its founding, the biochemical company made the leap to Euronext, the European stock exchange. Since then, several industrial partnerships have followed one after the other.

At 38%, the construction industry is responsible for a large share of global greenhouse gas emissions. As the demand for housing increases, sustainable building materials are urgently needed to avoid further burdening the environment and climate. Researchers at the University of Göttingen have found an ecological alternative for dry construction with a new process that can be used to manufacture numerous products from hemp, flax and popcorn granules.

Palm oil is one of the most versatile and sought-after vegetable oils: it is found in many foods such as ice cream, chocolate and potato chips, and is also used in the production of cosmetics and biodiesel. Yet palm oil cultivation in countries such as Malaysia and Indonesia has economic, social and also environmental consequences, and has therefore long been controversial. A research consortium is now working on a domestic alternative to palm oil. The NextVegOil project focuses on developing a process for producing a microbial oil based on agricultural residues.

Plants need not only sunlight but also water from the soil to grow. However, the past three years of heat and drought have upset this necessary balance. The consequences are already manifold: in addition to crop failures, pests such as the bark beetle have decimated the tree population of forests in many places. A study by researchers from Germany, the Netherlands and Australia now shows what impact climate change will have on plants and ecosystems.

The Wacker Group hopes to generate sales of around EUR 1 billion in 2030 from the Wacker Biosolutions business segment, which bundles biotechnology activities. A now announced investment in the double-digit millions is expected to contribute to this: the Group plans to build and commission a Biotechnology Center at its Munich site by 2024.